MEDICAL MOMENT: IMPORTANT NEWS
News about Alnylam's clinical program for Givosiran can be viewed by clicking the link below for the press release.
Givosiran is an investigational RNAi therapeutic in development for the treatment of acute porphyrias.
Link: http://investors.alnylam.com/releasedetail.cfm?ReleaseID=1028383
"Remember....Research is the key to your cure!"
